Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- People who have been diagnosed with colorectal cancer (confirmed through a lab test of tissue) and are scheduled to have surgery with the goal of curing the cancer, followed by standard medical check-ups.
Who may not be able to join:
- People who are unable or unwilling to sign the form giving their agreement to take part in the trial.
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sebastian Meltzer, M.D., Ph.D., University Hospital, Akershus
Phone: +4767960000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical logistics pipeline for patient-derived organoid development success rate; Sensitivity report for chemotherapy and cellular immunotherapy by clinical evaluation; Induction of immunotherapy efficacy by chemotherapy in colorectal cancer, measured by advanced imaging analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.